Dietary intakes of anthocyanins and cardiometabolic health: a systematic review and meta-analysis of randomized trials and prospective cohort studies in healthy
Meta-analyses support anthocyanins' cardiometabolic benefits in heterogeneous populations (including diseased), but efficacy in healthy participants remains unknown. Across prospective cohorts, and randomized controlled trials (RCTs; ≥50 mg/d anthocyanins), we assessed impac
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.